PM Equity Partner offers various type of collaboration agreements and investment formats. To date PM Equity Partner has invested in sixteen companies with selected examples below:
Supplement product gums and mints to energize, calm and focus by providing key nutrients for improved performance up to 5 times more quickly than drinks or capsules and without the effects of caffeine. Anytime, anywhere.
Moodify Scent Technologies enable brands and fragrance houses to create and control scent experiences for their products. Scents developed with Moodify have radically reduced time and cost to market, enabling scalable, sustainable, and compliant production.
Moodify’s multi-patented Scent AI™ technologies combine deep scent industry expertise with advanced machine learning, physics, chemistry and neuroscience to crack the code of dynamic scent development and delivery.
Moodify solutions include Malodor Control for packaged goods, places and pets, and Reformulations for personal care and home care. Moodify also partners with product innovators from entertainment and retail to consumer electronics, creating new dynamic scent experiences that their customers will love.
Moodify is based on tight collaboration with the Weizman Olfactory Research Group, combining over a decade of academic research with cutting-edge industry knowledge in computer science, material science, and fragrance design.
Comet Bio is an award-winning food technology company based in London, Ontario, and Schaumburg, Illinois. The company makes unique, healthy, and sustainable products using its patented upcycling technology. Its Arrabina Arabinoxylan Plant Fiber Extract is a premium prebiotic dietary fiber with superior tolerability and functionality. The company's line of Sweeterra syrups is a sustainable and lower sugar alternative to traditional sweeteners with no trade-offs in terms of taste and performance.
Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development. The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision-making.
PM Equity Partner has exited its investment in Biognosys.
Treatech is disrupting the waste water treatment industry by bringing to market an innovative technology that captures the full value of a broad range of end products including renewable gas, clean water, salt, and minerals.
In 2023, PM Equity Partner has successfully exited its investment in Treatech as part of a Series A funding led by strategic investors.
Azuri has delivered affordable solar home systems on a commercial basis to customers in 12 countries in sub-Saharan Africa. The company has sold more than 150,000 systems, impacting more than 750,000 lives.
Azuri's long-term vision is to bridge the digital and services gap that exists between urban and rural communities through the power of solar.
Softhale is developing pharmaceutical inhalation products for major respiratory markets in the U.S., Europe, and Asia. These products are based upon a differentiated inhalation delivery technology called SOFTHALER®. This device is a next-generation Soft Mist Inhaler (SMI), which offers a platform technology for delivering various drugs to the lungs. As well as generic products, innovative products are also targeted.
PM Equity Partner has exited its investment in Softhale.
Supplement product gums and mints to energize, calm and focus by providing key nutrients for improved performance up to 5 times more quickly than drinks or capsules and without the effects of caffeine. Anytime, anywhere.
Moodify Scent Technologies enable brands and fragrance houses to create and control scent experiences for their products. Scents developed with Moodify have radically reduced time and cost to market, enabling scalable, sustainable, and compliant production.
Moodify’s multi-patented Scent AI™ technologies combine deep scent industry expertise with advanced machine learning, physics, chemistry and neuroscience to crack the code of dynamic scent development and delivery.
Moodify solutions include Malodor Control for packaged goods, places and pets, and Reformulations for personal care and home care. Moodify also partners with product innovators from entertainment and retail to consumer electronics, creating new dynamic scent experiences that their customers will love.
Moodify is based on tight collaboration with the Weizman Olfactory Research Group, combining over a decade of academic research with cutting-edge industry knowledge in computer science, material science, and fragrance design.
Comet Bio is an award-winning food technology company based in London, Ontario, and Schaumburg, Illinois. The company makes unique, healthy, and sustainable products using its patented upcycling technology. Its Arrabina Arabinoxylan Plant Fiber Extract is a premium prebiotic dietary fiber with superior tolerability and functionality. The company's line of Sweeterra syrups is a sustainable and lower sugar alternative to traditional sweeteners with no trade-offs in terms of taste and performance.
Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development. The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision-making.
PM Equity Partner has exited its investment in Biognosys.
Treatech is disrupting the waste water treatment industry by bringing to market an innovative technology that captures the full value of a broad range of end products including renewable gas, clean water, salt, and minerals.
In 2023, PM Equity Partner has successfully exited its investment in Treatech as part of a Series A funding led by strategic investors.
Azuri has delivered affordable solar home systems on a commercial basis to customers in 12 countries in sub-Saharan Africa. The company has sold more than 150,000 systems, impacting more than 750,000 lives.
Azuri's long-term vision is to bridge the digital and services gap that exists between urban and rural communities through the power of solar.
Softhale is developing pharmaceutical inhalation products for major respiratory markets in the U.S., Europe, and Asia. These products are based upon a differentiated inhalation delivery technology called SOFTHALER®. This device is a next-generation Soft Mist Inhaler (SMI), which offers a platform technology for delivering various drugs to the lungs. As well as generic products, innovative products are also targeted.
PM Equity Partner has exited its investment in Softhale.
Avenue de Rhodanie 50
1007 Lausanne
Switzerland
Phone: +41 58 242 00 00
Email: info.pmep@pmi.com
©2023 PM Equity Partner - Legal Page - Privacy Notice - Cookie preferences
